Daniel Clark

Stock Analyst at Leerink Partners

(0.53)
# 3,821
Out of 4,711 analysts
3
Total ratings
n/a
Success rate
-3.29%
Average return

Stocks Rated by Daniel Clark

Elanco Animal Health
Dec 2, 2024
Initiates: Market Perform
Price Target: $14
Current: $11.63
Upside: +20.38%
IDEXX Laboratories
Dec 2, 2024
Initiates: Outperform
Price Target: $500
Current: $412.26
Upside: +21.28%
Zoetis
Dec 2, 2024
Initiates: Outperform
Price Target: $215
Current: $164.84
Upside: +30.43%